ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 7 analysts with an average price target of $58.45. This is a potential upside of $20.6 (54.43%) from yesterday's end of day stock price of $37.85.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 247 price targets and 190 ratings on display. The stock rating distribution of ARWR is 88.24% BUY and 11.76% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.59% with an average time for these price targets to be met of 272.05 days.

Highest price target for ARWR is $80, Lowest price target is $17, average price target is $45.86.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 11-Aug-2025. First documented stock forecast 05-Mar-2014.

Currently out of the existing stock ratings of ARWR, 15 are a BUY (88.24%), 2 are a HOLD (11.76%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$60

$17.61 (41.54%)

$60

2 months 24 days ago
(11-Aug-2025)

4/21 (19.05%)

$42.79 (248.63%)

193

Buy

$80

$37.61 (88.72%)

$80

5 months 15 days ago
(20-May-2025)

0/22 (0%)

$63.71 (391.10%)

Buy

$40

$-2.39 (-5.64%)

$42

5 months 22 days ago
(13-May-2025)

5/11 (45.45%)

$24.72 (161.78%)

206

Hold

$17

$-25.39 (-59.90%)

$26

5 months 22 days ago
(13-May-2025)

5/6 (83.33%)

$1.72 (11.26%)

54

Buy

$38

$-4.39 (-10.36%)

$55

8 months 21 days ago
(14-Feb-2025)

9/16 (56.25%)

$18.05 (90.48%)

147

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 272.05 days on average for the stock forecasts to be realized with a an average price target met ratio 69.59

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

LUCA ISSI

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Luca Issi works at RBC and has 14 price targets and 9 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Esther Rajavelu with highest potential upside - $59.61

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Shawn Egan with lowest potential downside - -$25.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?